Analysis on the Correlation Between RUNX3 Mislocalization and Epigenetic Parameters in Non-Small Cell Lung Cancer

被引:0
|
作者
Liu, W. [1 ,2 ]
Huang, C. [1 ,3 ]
Shi, Y. [4 ,5 ]
Lu, J. [4 ]
Chen, X. [1 ,2 ,5 ]
机构
[1] Fujian Med Univ, Grad Sch, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Thorac Surg, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Fujian, Peoples R China
[3] Fujian Med Univ, Clin Oncol Sch, Lab Immunooncol, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Fujian Med Univ, Dept Pathol, Clin Oncol Sch, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[5] Fuzhou Univ, Interdisciplinary Inst Med Engn, Fuzhou, Peoples R China
关键词
runt-related transcription factor 3; promoter hypermethylation; non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP.02B.06
引用
收藏
页码:S438 / S439
页数:2
相关论文
共 50 条
  • [21] Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer
    Cai, Liangliang
    Bai, Hua
    Duan, Jianchun
    Wang, Zhijie
    Gao, Shugeng
    Wang, Di
    Wang, Shuhang
    Jiang, Jun
    Han, Jiefei
    Tian, Yanhua
    Zhang, Xue
    Ye, Hao
    Li, Minghui
    Huang, Bingding
    He, Jie
    Wang, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [22] Positive Correlation between Cyclooxygenase 2 and the Expression of ABC Transporters in Non-small Cell Lung Cancer
    Surowiak, Pawel
    Pawelczyk, Konrad
    Maciejczyk, Adam
    Pudelko, Marek
    Kolodziej, Jerzy
    Zabel, Maciej
    Murawa, Dawid
    Drag, Marcin
    Gansukh, Tserenchunt
    Dietel, Manfred
    Lage, Hermann
    ANTICANCER RESEARCH, 2008, 28 (5B) : 2967 - 2974
  • [23] Correlation Between Inflammatory Markers and Oncological Outcomes in Surgically Resected Non-Small Cell Lung Cancer
    Waseda, R.
    Miyahara, N.
    Moroga, T.
    Wakahara, J.
    Mei, H.
    Yamamoto, L.
    Imamura, N.
    Miyahara, S.
    Shiraishi, T.
    Iwasaki, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S704 - S704
  • [24] Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers
    Yanagawa, Naoki
    Tamura, Gen
    Oizumi, Hiroyuki
    Kanauchi, Naoki
    Endoh, Makoto
    Sadahiro, Mitsuaki
    Motoyama, Teiichi
    LUNG CANCER, 2007, 58 (01) : 131 - 138
  • [25] Histopathological Risk Factors Correlation in Patients with Non-Small Cell Lung Cancer
    Pritami, A. A.
    Infianto, A.
    Soemarwoto, R. A. S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S416 - S416
  • [26] Volume and dose parameters for survival of non-small cell lung cancer patients
    Martel, MK
    Strawderman, M
    Hazuka, MB
    Turrisi, AT
    Fraass, BA
    Lichter, AS
    RADIOTHERAPY AND ONCOLOGY, 1997, 44 (01) : 23 - 29
  • [27] Angiogenesis and non-small cell lung cancer
    Cox, G
    Jones, JL
    Walker, RA
    Steward, WP
    O'Byrne, KJ
    LUNG CANCER, 2000, 27 (02) : 81 - 100
  • [28] Oligoprogression in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    CANCERS, 2021, 13 (22)
  • [29] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [30] Docetaxel and non-small cell lung cancer
    Le Guen, Y
    Le Cesne, A
    BULLETIN DU CANCER, 2004, 91 (03) : 263 - 270